Life Sciences Greenhouse Investments Announces Appointment of Two New Directors
January 26 – Harrisburg, PA. Life Sciences Greenhouse Investments (www.LSGPA.com) is pleased to announce that Rebecca Stametz, DEd, MPH, and Haichen Yang, MD, MBA, have joined the Board of Directors. Dr. Stametz is Vice President Digital Transformation, Geisinger Steele Institute for Health Innovation. Dr. Yang is Vice President of Clinical Research, Amicus Therapeutics.
“Drs. Stametz and Yang bring deep expertise in particularly promising subsectors of the life sciences to LSG Investments,” said Board Chair Tom Penn. “Their contributions will help ensure that our investments are attuned to the needs of patients and clinicians and aligned with the demands of the healthcare marketplace.”
Dr. Stametz is an accomplished healthcare-transformation executive with over 15 years of experience. Her work focuses on strategic design, development, and deployment of digital strategies, including building custom solutions for the healthcare marketplace. She serves as the executive leader of the Digital Transformation Office within the Steele Institute for Health Innovation at Geisinger, a large integrated health system serving the northeast and central Pennsylvania.
Dr. Yang is an accomplished pharmaceutical executive and drug development expert with over 28 years of experience in neurology, psychiatry, pain, and metabolic disorders. She has led many successful clinical development programs, including several that resulted in new drug and indication approvals, such as Fycompa®, Keppra®, and Luvox CR®. Dr. Yang is currently a Vice President of Clinical Research at Amicus Therapeutics. She was previously a Vice President at ICON plc where she provided strategic drug development consulting services. She has also worked for Eli Lilly, Solvay, UCB, and Eisai.
About Life Sciences Greenhouse Investments
Life Sciences Greenhouse Investments provides funding and targeted business advice to help startup life science companies bring life-changing technologies to market. By enhancing the viability of innovative technologies that advance patient care, and fostering company growth and job creation, LSG Investments is strengthening Pennsylvania’s vibrant life sciences ecosystem and improving healthcare outcomes for patients around the world.
Since LSG Investments was founded in 2002 as Life Sciences Greenhouse of Central PA, the evergreen venture fund has invested $37 million into 72 companies and projects that collectively have created and retained 8,500 direct and indirect jobs in the Commonwealth. Today, more than 152 products developed by LSG Investment-funded companies are currently marketed or in development.
Contact:
Michele Washko
mwashko@LSGPA.com
717-514-0436
